The Effect of PPI Use on Human Gut Microbiota and Weight Loss in Patients Undergoing Laparoscopic Roux-en-Y Gastric Bypass

Laparoscopic Roux-en-Y gastric bypass (LRYGB) achieves sustainable weight loss possibly by altering the gut microbiota. The effect of a proton pump inhibitor (PPI) on weight loss and the gut microbiota has not been explored. PPI use and the gut microbiota were assessed before and 6 months after LRYG...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Obesity surgery 2014-09, Vol.24 (9), p.1567-1571
Hauptverfasser:	Ward, Emily K., Schuster, Dara P., Stowers, Katie H., Royse, Amanda K., Ir, Diana, Robertson, Charles E., Frank, Daniel N., Austin, Gregory L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Bacteroidetes - genetics Body Mass Index Brief Communication Case-Control Studies Drug therapy Female Gastric Bypass Gastrointestinal surgery Humans Intestines - microbiology Laparoscopy Male Medicine Medicine & Public Health Microbiology Microbiota - genetics Middle Aged Obesity Obesity, Morbid - surgery Proteobacteria - genetics Proton Pump Inhibitors - therapeutic use RNA, Ribosomal, 16S - genetics Surgery Treatment Outcome Verrucomicrobia - genetics Weight Loss Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!